Author:
Saber Haleh,Leighton John K.
Subject
Toxicology,General Medicine
Reference16 articles.
1. FDA Approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer;Amiri-Kordestani;Clin. Cancer Res.,2014
2. Approval summary gemtuzumab ozogamicin in relapsed acute meyloid leukemia;Bross;Clin. Cancer Res.,2001
3. U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma;de Claro,2012
4. Regulatory considerations for preclinical development of anticancer drugs;Degeorge;Cancer. Chemother. Pharmacol.,1998
5. Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies;Ducry;Bioconjug. Chem.,2010
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献